to NGF treatment (Greene and Tischler, 1976) . As shown in Figure 1D , activity in the naive, proliferating cells was genes in G1 and induce their expression in G1/S and S (Dyson, 1998) . Because postmitotic neurons are perma-7-fold higher than in neuronal cells. This ratio is similar to that for the mutant versus wild-type reporter in the nently in G0/G1, we first determined whether the E2F sites in such cells are in a repressive state. as well as hyperphosphorylation and loss of pocket proprotein hyperphosphorylation and degradation (Park et al., 1997b) . These findings thus demonstrate that DNA teins (Park et al., 1998 . This also leads to loss of E2F-Rb family complexes as judged by gel shift assays damage to neurons evokes a rapid, CDK-dependent decrease in repression of E2F-responsive genes. (data not shown). We reasoned that the E2F-dependent gene repression present in healthy neurons may therefore be compromised in response to DNA damage. To
The E2F-Repressed Genes B-myb and C-myb Are Upregulated in Neurons test this possibility, we assessed the relative levels of luciferase transcripts in neurons transfected with the To investigate the regulation of endogenous E2F-repressed genes in response to DNA damaging agents, Bmyb-luc reporter and exposed to camptothecin for various times. The data in Figure 1E indicate that campwe first carried out semiquantitative RT-PCR on B-myb mRNA isolated from cortical neurons treated for various tothecin promotes a rapid increase in luciferase transcripts. Similar findings were achieved with UV treattimes with camptothecin. As shown in Figure 2A , under the conditions of our PCR assay, we detected a PCR ment as well as with cdc25-luc and DHFR-luc reporters and with neuronal PC12 cell cultures (data not shown). fragment of the expected length only after 6 and 12 hr of camptothecin treatment, indicating that DNA damage Cotreatment with actinomycin D or flavopiridol blocked the increase. Flavopiridol is a CDK inhibitor that protects leads to elevated B-myb expression. In contrast, GAPDH-specific primers generated the expected PCR neurons from camptothecin and other DNA damaging agents and that blocks DNA damage-induced pocket product with equal intensity at all time points of treat- Figure 2B , levels of B-myb Taken together, the above findings indicate that the B-and C-myb genes, whose expression is repressed by transcripts doubled within 1-2 hr of camptothecin exposure. Parallel experiments revealed a similar response E2F, undergo rapid increases in expression in neurons subjected to DNA damage. These observations indicate of C-myb mRNA ( Figure 2C ). These increases were prevented by actinomycin D (Figures 2B and 2C ) as well that DNA damage evokes derepression of E2F-regulated transcripts in neurons. as by flavopiridol ( Figure 2C ). The data shown in Figure  2E confirm that both actinomycin and flavopiridol also protected cortical neurons from camptothecin-induced Expression of E2F Mutant Constructs Promotes Neuronal Apoptosis: Role of Gene Derepression death in these studies.
To examine whether DNA damage also affects the Although the above observations indicate that DNA damage causes E2F-dependent derepression, they do levels of the B-myb and C-myb proteins in neuronal cells, we performed Western blot analyses of whole-cell not exclude an accompanying elevation in E2F-dependent gene transactivation and therefore do not distinextracts of UV-and camptothecin-treated PC12 cells and cortical neurons. As shown in Figures 3A and 3B , guish between the potential roles of these two responses in neuronal death. To achieve this distinction, levels of B-myb protein increased within 2 hr of treatment and remained elevated for at least 12 hr. Similar we transfected a variety of E2F1 constructs ( Figure 4A ) into neuronal cells and monitored their effects on Bmybresults were found for levels of C-myb protein in UV-(data not shown) or camptothecin-treated (Figures 3C luc activity and survival. E2F1(1-368) is a truncated form of E2F1 that lacks and 3D) cortical neurons. The increases in Myb proteins were suppressed by flavopiridol ( Figures 3A-3C ), actinoboth the activation and Rb binding domains ( Figure 4A ; Sellers et al., 1995) . This therefore acts as a dominant mycin D (Figure 3D ), or cyclohexamide ( Figure 3D ), indicating the elevated protein levels were dependent on negative that suppresses E2F1-dependent transactivation and, by virtue of its inability to bind pocket proteins, both ongoing transcription and translation as well as on CDK activity. displaces endogenous E2F complexes, causing derepression of certain E2F-responsive genes in neurons We next determined whether the elevated levels of Myb proteins in camptothecin-treated neurons have the (Zhang et al., 1999) . Figure 4B shows that cotransfection of E2F1(1-368) along with Bmyb-luc resulted in incapacity to bind DNA. Figure 3E and 5B), dogenous E2F-repressive complexes, the death response to their expression should not be attributable to sympathetic neurons ( Figures 5D and 5E ), and cortical neurons (data not shown). In each culture type, in con-E2F-mediated gene activation but rather to E2F derepression. To further test this hypothesis, we employed trast to their huge disparity in upregulating B-myb promoter activity, both constructs were similarly effective an additional E2F1 mutant, E2F1(E132), which has mutations that abolish its E2F site binding activity (Johnson in promoting massive death. Similar findings were achieved with E2F1(FS409) (data not shown).
et al., 1993). This mutant should not directly displace endogenous E2F1 complexes from DNA but should The above findings are consistent with the interpretation that both wild-type and E2F1 mutants induce death rather compete for pocket proteins, thereby alleviating the repressive effect of endogenous E2F-pocket protein by displacing endogenous repressive E2F-pocket protein complexes, thereby relieving repression of genes complexes. As shown in Figure 4B , E2F1(E132) enhances the expression of Bmyb-luc to a degree similar to including those that promote death. Since the E2F mutant constructs lack transactivation activity but possess that achieved with E2F1(1-368). Moreover, this construct was also comparably effective in inducing death of neu-DNA binding activity that permits displacement of en- 
Forced Expression of B-myb and C-myb Induces Neuronal Death indicating that E2F in neuronal cells is repressed to such a level that expression of another E2F repressor does
If derepression of E2F-responsive genes plays a role in the neuronal apoptotic response, then forced expresnot further affect reporter activity. In contrast, E2F1(1-368)-Rb(379-928)⌬ex22 coexpression increased resion of at least some of these might be anticipated to induce death. To test this, we transfected neuronal PC12 porter activity by 2.5-fold (Figure 4B ), indicating that this elevated by 6-fold within 10 hr ( Figure 1F ), indicating that NGF withdrawal relieves repression of the B-myb promoter by E2F. In support of the latter, this upregulation was blocked by the presence of flavopiridol ( Figure  1F) . Examination of the endogenous levels of C-myb transcripts confirmed that these undergo a similar elevation following NGF withdrawal and revealed that flavopiridol eliminated this response ( Figure 2D ). We also observed an increase in levels of endogenous B-myb protein within 2 hr of NGF withdrawal (data not shown). Thus, derepression of the Myb promoters is induced by NGF withdrawal as well as by DNA damaging agents. We next tested whether blockade of E2F derepression by the E2F-Rb fusion protein would protect neurons from apoptosis induced by NGF withdrawal ( Figure 7C ). We cotransfected sympathetic neurons with GFP and different Rb constructs, and, 2 days later, NGF was removed and the medium replaced with one containing anti-NGF antibody. Counts of GFP-positive neurons revealed that E2F1(1-368)-Rb(379-792) promoted survival rates of 95% and 88% after 1 and 2 days of NGF withdrawal, respectively. In contrast, the corresponding mutant version of the fusion protein, E2F1(1-368)-Rb(379- 
days, respectively). These results indicate that E2F B-myb and C-myb were cotransfected with pEGFP, and survival was derepression is an underlying mechanism of apoptosis assessed both as percentage of surviving GFP-positive cells (A) and evoked by NGF withdrawal as well as by DNA damage. as percentage of apoptotic nuclei (B). Data are given as means Ϯ SEM (n ϭ 3). (C and D) B-myb and C-myb cause apoptosis in cortical neurons
Discussion even when derepression of E2F-responsive genes is blocked. Neurons were cotransfected with pEGFP and the indicated constructs. supported by our observations that E2F-tethered Rb effectively protected neurons from death evoked by either DNA damage or NGF withdrawal.
Role of E2F-Dependent Gene Repression and

Survival was accessed as in (A) and (B). Data are given as means Ϯ
Derepression in Neuronal Survival and Death
Regulation of E2F-Mediated Derepression
Although our data are consistent with the required Recent studies suggest a sequential role for E2F-depeninvolvement of E2F-mediated gene derepression in neudent derepression and activation in cell cycle progresronal death, they do not support an obligatory role for sion ( ated kinase activity promotes hyperphosphorylation of pocket proteins bound to E2F, which compromises their DNA damage and NGF deprivation, lead to events that favor E2F-promoted gene derepression and that this, capacity to mediate gene repression. The consequent deregulation of genes elevates cellular levels of proaporather than E2F-dependent gene activation, plays a required role in neuronal apoptosis. For instance, neuronal ptotic proteins that contribute to neuronal death. Although the E2F derepression pathway described death is blocked by G1/S inhibitors but not by those acting at later stages in the cell cycle (Farinelli and here may be required and sufficient for neuronal death, this does not exclude involvement of other pathways in . This suggests a particular vulnerability at the G1/S checkpoint, which is at the place in the cycle this regard. For instance, activation of the JNK/c-Jun pathway also appears to be required for neuronal death at which E2F-mediated derepression appears to occur (Harbour et al., 1999) . In addition, dominant-negative evoked by DNA damage and NGF deprivation as well as additional causes (Maroney et al., 1999). However, CDK4 and CDK6 protect neurons from apoptosis evoked by DNA damaging agents and NGF withdrawal, whereas activation of the two pathways appears to be independent (Park et al., 1996b) . In addition, p53 also appears dominant-negative CDK2 does not (Park et al., 1997a (Park et al., , 1998 was carried out using Superscript II reverse transcriptase (Life TechTransfection protocols were as follows. nologies) following the manufacturer's instructions. Semiquantita-PC12 Cells tive PCR (GeneAmp PCR System 9700, Perkin-Elmer) was carried Naive or neuronal PC12 cells in 24-well dishes were transfected out using Platinum Taq DNA polymerase (Life Technologies) followusing LipofectAMINE plus or LipofectAMINE 2000 (Life Technoloing the manufacturer's instructions. For B-myb, oligonucleotides gies) following the manufacturer's standard protocol. All cDNA con-GGGCTCAGGCATTGGCACACC and GTGTGGGGAGTGTTGTCC structs were used at 1 g/well; E2F decoys were at 0.5 g/well.
ATGG were used (27 to 29 cycles). For GAPDH, oligonucleotides Cortical Neurons ACCACAGTCCATGCCATCAC and TCCACCACCCTGTTGCTGTA Transfection of cortical neurons was carried out 3 days after plating were used (20 to 21 cycles). as described for PC12 cells, except that the transfection medium Quantitative PCR was carried out using a Cepheid SmartCycler was replaced with fresh medium after 5-6 hr.
following the manufacturer's specifications. cDNA was added to a Sympathetic Neurons 25 l volume reaction mix containing Ready-to-go Beads (AmerOn the third day after plating, neurons were transfected with a Helios sham Manheim Pharmaceuticals) and SYBR Green I (Molecular Gene Gun System (BioRad). In brief, DNA was loaded on microcarProbes) together with appropriate primers at 0.2 M each. Analyses riers (1.6 m) with a ratio of DNA:gold carrier (2 g:1 mg) according of growth curves of real-time fluorescence and of melting curves to manufacturer's protocol (BioRad). Medium was carefully removed were carried out as described before (Troy et al., 2001 ). GAPDH from the wells shortly before shooting and replaced immediately was used to normalize input cDNA. Levels of luciferase mRNA in after. The Gene Gun was held perpendicularly over the culture dish reporter transfection assays were also normalized by ␤-gal mRNA and about 1.5 cm above the surface of the cell layer. Pressure was levels. The same oligonucleotides listed above were used for B-myb set at 200 psi. Even distribution of gold particles was monitored by and GAPDH: CGGTCCCCTGAAGATGCTACCT and GGTCCTCTG microscopic observations. TCTTCCCACAGGA for C-myb; CGCTGCTGGTGCCAACCCT and GGCGTTGGTCGCTTCCGGA for luciferase; CCGACCCAGCGCCCG TTGCA and GGCCCGCACCGATCGCCCTT for ␤-gal. 
